Two Sigma Securities, LLC Ampio Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $1,796 - $471,618	-22,458 Reduced 45.08%	27,364 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $7,971 - $23,416	49,822 New	49,822 $8,000
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $10,622 - $15,681	-25,292 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $14,163 - $43,249	25,292 New	25,292 $14,000
Q4 2020 Feb 16, 2021	SELL	$0.75 - $2.76 $9,111 - $33,531	-12,149 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.61 - $1.17 $7,410 - $14,214	12,149 New	12,149 $12,000
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $17,459 - $40,178	-10,518 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $22,718 - $36,602	10,518 New	10,518 $36,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.